The Clorox Company
CLX · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $15 | $15 | $18 | $20 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $3 | $3 | $3 | $3 |
| Enterprise Value | $18 | $18 | $21 | $23 |
| Revenue | $1 | $2 | $2 | $2 |
| % Growth | -28.1% | 19.2% | -1.1% | – |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 41.6% | 46.3% | 44.3% | 43.6% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 13.2% | 24.7% | 20.1% | 18.7% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 5.6% | 16.7% | 11.2% | 11.4% |
| EPS Diluted | 0.65 | 2.68 | 1.5 | 1.54 |
| % Growth | -75.7% | 78.7% | -2.6% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |